Subgroups of Clinical High Risk for Psychosis Based on Baseline Antipsychotic Exposure: Clinical and Outcome Comparisons Across a 2-Year Follow-up Period.
Lorenzo PelizzaAlessandro Di LisiEmanuela LeuciEmanuela QuattroneSilvia AzzaliSimona PupoGiuseppina PaulilloPietro PellegriniMarco MenchettiPublished in: Schizophrenia bulletin (2024)
Our results suggest that baseline AP need is an important prognostic parameter in CHR-P and should be considered in risk/benefit calculators.
Keyphrases